ERBB2 and laryngotracheoesophageal cleft: No oncogenic driver gene mutations were detected from these four patients except ERBB2 amplification, suggesting mutual exclusivity between ERBB2ΔEx16 and established drivers, and therefore a potential oncogenic role of ERBB2ΔEx16 in LC.